Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. Melphalan-prednisone in the phase III VISTA trial in multiple myeloma

1. Delforge, M.
2. Terpos, E.
3. Richardson, P.G.
4. Shpilberg, O.
5. Khuageva, N.K.
6. Schlag, R.
7. Dimopoulos, M.A.
8. Kropff, M.
9. Spicka, I.
10. Petrucci, M.T.
11. Samoilova, O.S.
12. Mateos, M.-V.
13. Magen-Nativ, H.
14. Goldschmidt, H.
15. Esseltine, D.-L.
16. Ricci, D.S.
17. Liu, K.
18. Deraedt, W.
19. Cakana, A.
20. Van de Velde, H.
21. San Miguel, J.F.